Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Mucosal Autoimmunity

 

Cecile King's lab is interested mucosal autoimmunity. In type 1 diabetes (T1D), the insulin-producing beta cells of the pancreas are destroyed by selftissue- destructive T cells. These cells express markers that help us to determine, for example, their dependence upon growth factors and where they have been in the body. We are particularly interested in the relationship between the cells that cause T1D and other autoimmune diseases that develop at the mucosal interface between our bodies and the environment. Broad-based suppression is commonly used to treat autoimmune diseases and transplant recipients but it has an obvious drawback since we need a functioning immune system in order to thrive. The aim of our research is to identify target molecules for selective suppression of these self-tissue-destructive cells. 



Staff


Postgraduate Student
Helen McGuire Helen McGuire
Postgraduate Student
Alexis Vogelzang


nacer_boubenna90.jpgPostgraduate Student
Nacer Boubenna



News

 

Finding suggests novel ways to boost vaccination or natural defences

MEDIA RELEASE: 07 Jul 2008
Our bodies rely on the production of potent, or 'high affinity', antibodies to fight infection. The process is very complex, yet Garvan scientists have discovered that it hinges on a single molecule, a growth factor, without which it cannot function. This suggest ways to strengthen the body's natural defences.
 
 

Personal tools